2 min Read

Cipla Q3 results: highlights

Cipla, the Indian pharmaceutical giant, delivered a resounding performance in its third quarter of FY2024, showcasing remarkable growth and exceeding even the most optimistic estimates....

Market updates subscription
Like what you see?

Subscribe for regular updates

Zero spam. You can unsubscribe any time.
Privacy Policy
+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91